000 04348nam a2200409 i 4500
999 _c10216
_d10216
001 10216
003 ES-MaUEC
005 20210608040356.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180105s2018 gw | o |||| 0|eng d
020 _a9783319706221
024 7 _a10.1007/978-3-319-70622-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
041 0 _aeng
050 4 _a RC271
_b.I45 2018 EB
090 4 _aR-RZ
245 0 4 _aThe Basics of Cancer Immunotherapy
_cedited by Haidong Dong, Svetomir N. Markovic
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018
300 _a1 recurso en línea (X, 160 páginas)
_b8 ilustraciones, 4 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aThe Basic Concepts in Cancer Immunology and Immunotherapy -- Therapeutic Targets of FDA-approved Immunotherapies in Oncology -- Melanoma Immunotherapy -- Significance of Immune Checkpoints in Lung Cancer -- Immunotherapy for Genitourinary Cancers -- Next-generation Immunotherapy in Lymphoma Immunotherapy -- Combined Immunothepary with Conventional Cancer Treatment -- Immunotherapy for Other Malignancies -- Management of Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy -- Resources for Patients.
520 3 _aThis book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy.    The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease.   Researchers and academic professionals in the field of cancer immunotherapy will also find clear and useful information to help them communicate with patients or address unresolved problems.  Some key features of the book are: Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today’s daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney,  bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease.
650 7 _2embne
_aCáncer
_xInmunoterapia
_9348509
700 1 _aDong, Haidong.
_eeditor literario
700 1 _aMarkovic, Svetomir N.
_eeditor literario
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319706214
776 0 8 _iEdición impresa:
_z9783319706238
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-70622-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
_n0
998 _db
_zSI